Healthtech Investors & VC Firms in Spain

83 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
DR Droia Ventures LVGGJNLD40 people · Follows rounds	88🔒	Luxembourg	LU	Seed–Series B	$540K	+ Add to CRM
MO Moonfire Ventures MLAGAGAG12 people · Follows rounds	88🔒	London	GB	Pre-Seed–Seed	—	+ Add to CRM
IG IGNIA ÁRFSOGLK20 people · Leads rounds	88🔒	Mexico City	MX	Pre-Seed–Series A	$100K – $5M	+ Add to CRM
ID IDC Ventures ABDPLSRL42 people · Leads rounds	88🔒	Miami	US	Pre-Seed–Growth	—	+ Add to CRM
GI Gilde Healthcare AFEDGPHD26 people · Follows rounds	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $55M	+ Add to CRM
FO Foresight Group BFATACAB18 people	88🔒	London	GB	Seed–Growth	$1.3M – $6.3M	+ Add to CRM
AD AdBio partners MCAHCBEG21 people	88🔒	Paris	FR	Seed–Series A	—	+ Add to CRM
QU Quantonation CJOTWZJM15 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Growth	—	+ Add to CRM
DE Debiopharm Innovation Fund TMCTMCKP17 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Series A	$1M – $5M	+ Add to CRM
AM Amplo Ventures STDTARIC10 people · Follows rounds	88🔒	Houston	US	Seed–Series C	—	+ Add to CRM
IN Indico Capital Partners AACFRTRR11 people · Leads rounds	88🔒	Lisbon	PT	Seed–Growth	$250K – $10M	+ Add to CRM
BY Bynd Venture Capital FFLGSSTP8 people · Follows rounds	88🔒	Lisbon	PT	Pre-Seed–Series A	—	+ Add to CRM
EA Eaton Square BADBMUAM25 people	88🔒	London	GB	Series A–Growth	—	+ Add to CRM
AM Amino Collective MGFTCGES8 people	88🔒	Berlin	DE	Pre-Seed–Series A	$216K – $1.6M	+ Add to CRM
CT CTI Life Sciences Fund L.P. DMKPLRST9 people · Follows rounds	88🔒	Montréal	CA	Seed–Late Stage	—	+ Add to CRM
RO Rocket Internet SE OSAKALGJ10 people · Leads rounds	88🔒	Berlin	DE	Pre-Seed–Seed	—	+ Add to CRM
IN InfraVia Capital Partners	88🔒	Paris	FR	Growth	—	+ Add to CRM
IM IMPACT Partners ASAFCGER17 people	88🔒	Paris	FR	Seed	$54K – $5.4M	+ Add to CRM
VE Vesper Infrastructure Partners AMERGRGR19 people	88🔒	London	GB	Growth–Late Stage	—	+ Add to CRM
PA PAI Partners AAKBAAWP13 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
IN Innovation Nest WDDDGKKF9 people	88🔒	Kraków	PL	Seed–Series A	$108K – $1.1M	+ Add to CRM
YZ YZR Capital MFHEMSUK12 people · Leads rounds	88🔒	Munich	DE	Pre-Seed–Growth	—	+ Add to CRM
MA Marcole Investments MSTCPKAT13 people	88🔒	London	GB	Seed	—	+ Add to CRM
FU Future Positive Capital SHSFTWAT6 people · Follows rounds	88🔒	—	FR	Pre-Seed–Series A	—	+ Add to CRM

Droia Ventures

LuxembourgSeed–Series B$540K

LVGGJNLD40 people

Moonfire Ventures

LondonPre-Seed–Seed

MLAGAGAG12 people

IGNIA

Mexico CityPre-Seed–Series A$100K – $5M

ÁRFSOGLK20 people

IDC Ventures

MiamiPre-Seed–Growth

ABDPLSRL42 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $55M

AFEDGPHD26 people

Foresight Group

LondonSeed–Growth$1.3M – $6.3M

BFATACAB18 people

AdBio partners

ParisSeed–Series A

MCAHCBEG21 people

Quantonation

ParisPre-Seed–Growth

CJOTWZJM15 people

Debiopharm Innovation Fund

LausannePre-Seed–Series A$1M – $5M

TMCTMCKP17 people

Amplo Ventures

HoustonSeed–Series C

STDTARIC10 people

Indico Capital Partners

LisbonSeed–Growth$250K – $10M

AACFRTRR11 people

Bynd Venture Capital

LisbonPre-Seed–Series A

FFLGSSTP8 people

Eaton Square

LondonSeries A–Growth

BADBMUAM25 people

Amino Collective

BerlinPre-Seed–Series A$216K – $1.6M

MGFTCGES8 people

CTI Life Sciences Fund L.P.

MontréalSeed–Late Stage

DMKPLRST9 people

Rocket Internet SE

BerlinPre-Seed–Seed

OSAKALGJ10 people

InfraVia Capital Partners

ParisGrowth

IMPACT Partners

ParisSeed$54K – $5.4M

ASAFCGER17 people

Vesper Infrastructure Partners

LondonGrowth–Late Stage

AMERGRGR19 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAKBAAWP13 people

Innovation Nest

KrakówSeed–Series A$108K – $1.1M

WDDDGKKF9 people

YZR Capital

MunichPre-Seed–Growth

MFHEMSUK12 people

Marcole Investments

LondonSeed

MSTCPKAT13 people

Future Positive Capital

Pre-Seed–Series A

SHSFTWAT6 people

Data sourced from public filings and firms' own websites — see our methodology.